Dianthus Therapeutics DNTH
NASDAQ DNTH
$108.10 +0.25 (+0.23%)
As of: Sep 4, 2026 · 3:59 PM EDT

Dianthus Therapeutics (DNTH) Assets (QoQ) (2018 - 2025)

Analysis

Dianthus Therapeutics (DNTH) Assets (QoQ) (2018 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Dianthus Therapeutics 4.09 Bn 3.69 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -8.06%
Sep 30, 2025 77.09%
Jun 30, 2025 -6.46%
Mar 31, 2025 -6.80%
Dec 31, 2024 5.58%
Sep 30, 2024 -3.99%
Jun 30, 2024 -3.53%
Mar 31, 2024 113.18%
Dec 31, 2023 -6.78%
Sep 30, 2023 144.74%
Jun 30, 2023 -5.76%
Mar 31, 2023 0.40%
Dec 31, 2022 -49.36%
Sep 30, 2022 -6.28%
Jun 30, 2022 -9.91%
Mar 31, 2022 2.34%
Dec 31, 2021 -7.90%
Sep 30, 2021 -6.42%
Jun 30, 2021 52.38%
Mar 31, 2021 -10.52%